KKR & Co. heads into its July 30 Q2 report with a 3.5% single-session gain on Friday doing little to repair a stock that remains deep in the hole for the year — and with a striking 24% gap between where the stock trades and where the Street thinks it belongs.
The most telling signal into the print is the options market's structural tilt toward puts. The put/call ratio has held near 1.85 for the past two weeks, well above its 52-week low of 0.98, and is essentially in line with its 20-day average — meaning the hedging bias has become the baseline rather than a fresh warning sign. That persistent defensiveness has built up alongside a stock that gained 6% over the past month but is still trading near $99, a level that many analysts view as materially cheap. The lending market adds no meaningful short-side signal: borrow availability is essentially unlimited, cost to borrow is barely above zero at 0.49%, and short interest has been falling — down 9% over the past week to 1.7% of the float. There is no squeeze dynamic here, and no accumulation of bearish bets in the lending pool.
The bull-bear debate is less about KKR's long-term model and more about the pace of recovery. Bulls point to diversified fee streams across private equity, infrastructure, and insurance, a fresh fundraising cycle gaining momentum, and a 12-month forward earnings growth profile that ranks in the 81st percentile. Bears flag a difficult exit environment, macro sensitivity in the insurance segment, and the persistent gap between fee-earning AUM growth and actual realizations. The analyst community is still broadly onside — every major firm that moved its target this month kept a positive rating, with Morgan Stanley maintaining Overweight even after trimming to $147. The consensus mean at $123 looks like a high bar at current levels, but the direction of cuts has been modest rather than alarming.
One ownership detail worth noting: KKR's own co-CEOs, Scott Nuttall and Joseph Bae, were buying stock aggressively in February and early March at prices ranging from the high-$80s to around $103 — a combined outlay well above $25 million. That cluster of executive buying now sits at a notable paper loss relative to Q2's peak but roughly at breakeven with current levels. It resets the stakes for Wednesday's print: management has skin in the game at prices very close to where the stock is trading now.
The July 30 release is ultimately a test of whether KKR's deployment activity and fee momentum in Q2 can narrow the credibility gap between a $99 stock and a $123 consensus — and whether management's own bullish bet on itself was well-timed.
See the live data behind this article on ORTEX.
Open KKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
